...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Re: Interim Analysis
5
Oct 15, 2020 08:26PM
6
Oct 16, 2020 09:29AM
2
Oct 16, 2020 09:58AM

KK2 -

This is correct, but if a combination of an SGLT2 inhibitor with ABL had a significantly greater impact on MACE than the SGLT2 inhibitor alone, it would be important. The design of BoM2 will need to take this into account, but that's not a big problem. 

Share
New Message
Please login to post a reply